Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 17, Number 4—April 2011


Secondary and Tertiary Transmission of Vaccinia Virus from US Military Service Member

Gregory E. YoungComments to Author , Christina M. Hidalgo, Ann Sullivan-Frohm, Cynthia Schulte, Stephen Davis, Cassandra Kelly-Cirino, Christina Egan, Kimberly Wilkins, Ginny L. Emerson, Kimberly Noyes, and Debra Blog
Author affiliations: Author affiliations: New York State Department of Health, Buffalo, New York, USA (G.E. Young, C.M. Hidalgo, A. Sullivan-Frohm); New York State Department of Health, Albany, New York, USA (C. Schulte, S. Davis, C. Kelly-Cirino, C. Egan, K. Noyes, D. Blog); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K. Wilkins, G.L. Emerson)

Main Article


Cases of laboratory-confirmed secondary and tertiary transmission of vaccinia virus from US military service member, New York, USA, 2010*

No.† Transmission
type Age, y/sex Exposure
Underlying risk factors VIG Duration of lesions, wk
Date Source Type Onset Location of lesions
1 Secondary 26/M Feb 27 Military vaccinee Wrestling Mar 1 Face, neck, chest None No ≈3
2 Secondary 24/M Feb 27 Military vaccinee Wrestling ≈Mar 1 Face, neck, chin, eye None No‡ ≈3
3 Tertiary 25/M Mar 5 Case-patient 1 Wrestling Mar 7 Chest, trunk, arm Mild eczema No ≈7
4 Tertiary 29/F After March Case-patient 1 Household Mar 9 Face, mandible, nostril None Yes ≈3

*VIG, varicella immune globulin.
†Case-patient no.
‡Use of VIG not indicated; treated with trifluridine ophthalmic solution (3).

Main Article